These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. No evidence for involvement of angiotensin II in spatial learning in water maze in rats. Chalas A; Conway EL Behav Brain Res; 1996 Nov; 81(1-2):199-205. PubMed ID: 8950017 [TBL] [Abstract][Full Text] [Related]
3. The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition. Costall B; Coughlan J; Horovitz ZP; Kelly ME; Naylor RJ; Tomkins DM Pharmacol Biochem Behav; 1989 Jul; 33(3):573-9. PubMed ID: 2685828 [TBL] [Abstract][Full Text] [Related]
4. The reduction in alcohol intake produced by enalapril is not attenuated by centrally administered angiotensin inhibitors. Robertson JM; Harding S; Grupp LA Alcohol; 1994; 11(4):295-9. PubMed ID: 7945983 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II inhibits the release of [3H]acetylcholine from rat entorhinal cortex in vitro. Barnes JM; Barnes NM; Costall B; Horovitz ZP; Naylor RJ Brain Res; 1989 Jul; 491(1):136-43. PubMed ID: 2765877 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus. Bild W; Hritcu L; Stefanescu C; Ciobica A Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():79-88. PubMed ID: 23266710 [TBL] [Abstract][Full Text] [Related]
9. Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE). DeForrest JM; Waldron TL; Harvey C; Scalese R; Hammerstone S; Powell JR; Karanewsky D J Cardiovasc Pharmacol; 1990 Jul; 16(1):121-7. PubMed ID: 1696654 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin I-converting enzyme inhibition increases cardiac catecholamine content and reduces monoamine oxidase activity via an angiotensin type 1 receptor-mediated mechanism. Raasch W; Bartels T; Gieselberg A; Dendorfer A; Dominiak P J Pharmacol Exp Ther; 2002 Feb; 300(2):428-34. PubMed ID: 11805201 [TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin II and an angiotensin converting enzyme inhibitor on alcohol intake in P and NP rats. Grupp LA Pharmacol Biochem Behav; 1992 Jan; 41(1):105-8. PubMed ID: 1539057 [TBL] [Abstract][Full Text] [Related]
12. Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm. Raghavendra V; Chopra K; Kulkarni SK Neuropeptides; 2001 Feb; 35(1):65-9. PubMed ID: 11346312 [TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition. Barnes JM; Barnes NM; Costall B; Horovitz ZP; Ironside JW; Naylor RJ; Williams TJ Brain Res; 1990 Jan; 507(2):341-3. PubMed ID: 2337775 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of central angiotensin converting enzyme ameliorates scopolamine induced memory impairment in mice: role of cholinergic neurotransmission, cerebral blood flow and brain energy metabolism. Tota S; Nath C; Najmi AK; Shukla R; Hanif K Behav Brain Res; 2012 Jun; 232(1):66-76. PubMed ID: 22460064 [TBL] [Abstract][Full Text] [Related]
16. The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates. Barnes JM; Costall B; Coughlan J; Domeney AM; Gerrard PA; Kelly ME; Naylor RJ; Onaivi ES; Tomkins DM; Tyers MB Pharmacol Biochem Behav; 1990 Apr; 35(4):955-62. PubMed ID: 2140610 [TBL] [Abstract][Full Text] [Related]
17. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876 [TBL] [Abstract][Full Text] [Related]
18. Modulation of sympathetic control by ACE inhibitors. Dominiak P Eur Heart J; 1993 Nov; 14 Suppl I():169-72. PubMed ID: 8293770 [TBL] [Abstract][Full Text] [Related]
19. Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats. Yamada K; Horita T; Takayama M; Takahashi S; Takaba K; Nagata Y; Suzuki N; Kanda T Brain Res; 2011 Nov; 1421():110-20. PubMed ID: 21981801 [TBL] [Abstract][Full Text] [Related]
20. Cognitive enhancing actions of DuP 753 detected in a mouse habituation paradigm. Barnes NM; Champaneria S; Costall B; Kelly ME; Murphy DA; Naylor RJ Neuroreport; 1990; 1(3-4):239-42. PubMed ID: 2129885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]